Hello,

We noticed you're browsing in private or incognito mode.

To continue reading this article, please exit incognito mode or log in.

Not a subscriber? Subscribe now for unlimited access to online articles.

Simson Garfinkel

A View from Simson Garfinkel

Dr. Ecstasy

Today’s New York TImes Magazine has a big article about Dr. Alexander Shulgin, who invented more than 100 hallucinogens and was, in all likelihood, the first person to try Ecstasy (MDMA) in humans. Shulgin is a really good guy, he’s…

  • January 30, 2005

Today’s New York TImes Magazine has a big article about Dr. Alexander Shulgin, who invented more than 100 hallucinogens and was, in all likelihood, the first person to try Ecstasy (MDMA) in humans. Shulgin is a really good guy, he’s previously been a consultant for the DEA, and he’s got a wicked-cool lab in California that I’ve visited on multiple occasions. Even if you’re not interested by psychedelic drugs, you should read this article — because Ecstasy is increasingly being put into trials as a possible cure for PTSD and other psychological disorders.

Want more award-winning journalism? Subscribe to Print + All Access Digital.
  • Print + All Access Digital {! insider.prices.print_digital !}*

    {! insider.display.menuOptionsLabel !}

    The best of MIT Technology Review in print and online, plus unlimited access to our online archive, an ad-free web experience, discounts to MIT Technology Review events, and The Download delivered to your email in-box each weekday.

    See details+

    12-month subscription

    Unlimited access to all our daily online news and feature stories

    6 bi-monthly issues of print + digital magazine

    10% discount to MIT Technology Review events

    Access to entire PDF magazine archive dating back to 1899

    Ad-free website experience

    The Download: newsletter delivery each weekday to your inbox

    The MIT Technology Review App

/3
You've read of three free articles this month. for unlimited online access. You've read of three free articles this month. for unlimited online access. This is your last free article this month. for unlimited online access. You've read all your free articles this month. for unlimited online access. You've read of three free articles this month. for more, or for unlimited online access. for two more free articles, or for unlimited online access.